Reassessment of the classification of the severity in idiopathic pulmonary fibrosis using SF-36 questionnaire

Internal Medicine

Volumn 44, Issue 3, 2005, Pages 196-199

  Ohno, Shoji ^a   Nakazawa, Shoko ^a   Kobayashi, Akira ^a   Bando, Masashi ^a   Sugiyama, Yukihiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Classification of the severity; IPF; QOL; SF 36

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FIBROSIS; LUNG FUNCTION TEST; MALE; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VITAL CAPACITY;

AGED; ANTIGENS; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; BIOPSY; FEMALE; GLYCOPROTEINS; HUMANS; HYDRO-LYASES; LUNG; MALE; MUCINS; PULMONARY FIBROSIS; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 17744376974     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.196     Document Type: Article

References (14)

1. American Thoracic Society, European Respiratory Society. ATS/ERS international multidisciplinary consensus classification of idiopathic interstitial pneumonia. Am J Respir Crit Care Med 165: 277-304, 2002 (Erratum in: Am J Respir Crit Care Med 166: 426, 2002).
2. Japan Intractable Diseases Information Center. http://www.nanbyou.or.jp Date updated; February 2004.
3. American Thoracic Society. European Respiratory Society. ATS/ERS international consensus statement: Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment. Am J Respir Crit Care Med 161: 646-664, 2000.
4. Fukuhara S, Suzukamo Y, Bito S, Kurokawa K. Manual of SF-36 Japanese version 1.2: Public Health Research Foundation, Tokyo, 2001.
5. Watters LC, King TE Jr, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 133: 97-103, 1986.
6. Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 167: 962-969, 2003.
7. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 35: 171-180, 1980.
8. Lama VN, Flaherty KR, Toews GB, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168: 1084-1090, 2003.
9. Chang JA, Curtis JR, Patrick DL, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 116: 1175-1182, 1999.
10. Martinez TY, Pereira CAC, dos Santos ML, Ciconelli RM, Guimaraes SM, Martinez JA. Evaluation of short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest 117: 1627-1632, 2000.
11. De Vries J, Kessels BL, Drent M. Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J 17: 954-961, 2001.
12. King TE Jr, Tooze J, Schwartz M, Brown K, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164: 1171-1181, 2001.
13. Flaherty KR, Mumford JA, Murray S, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168: 543-548, 2003.
14. Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwartz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168: 538-542, 2003.